GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alkem Laboratories Ltd (NSE:ALKEM) » Definitions » Shiller PE Ratio

Alkem Laboratories (NSE:ALKEM) Shiller PE Ratio : 45.69 (As of May. 15, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Alkem Laboratories Shiller PE Ratio?

As of today (2024-05-15), Alkem Laboratories's current share price is ₹5183.20. Alkem Laboratories's E10 for the quarter that ended in Dec. 2023 was ₹113.45. Alkem Laboratories's Shiller PE Ratio for today is 45.69.

The historical rank and industry rank for Alkem Laboratories's Shiller PE Ratio or its related term are showing as below:

NSE:ALKEM' s Shiller PE Ratio Range Over the Past 10 Years
Min: 32.07   Med: 41.62   Max: 47.99
Current: 45.21

During the past years, Alkem Laboratories's highest Shiller PE Ratio was 47.99. The lowest was 32.07. And the median was 41.62.

NSE:ALKEM's Shiller PE Ratio is ranked worse than
78.09% of 534 companies
in the Drug Manufacturers industry
Industry Median: 25.25 vs NSE:ALKEM: 45.21

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Alkem Laboratories's adjusted earnings per share data for the three months ended in Dec. 2023 was ₹49.760. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is ₹113.45 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Alkem Laboratories Shiller PE Ratio Historical Data

The historical data trend for Alkem Laboratories's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alkem Laboratories Shiller PE Ratio Chart

Alkem Laboratories Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Alkem Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 33.05 32.82 45.86

Competitive Comparison of Alkem Laboratories's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Alkem Laboratories's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alkem Laboratories's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Alkem Laboratories's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Alkem Laboratories's Shiller PE Ratio falls into.



Alkem Laboratories Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Alkem Laboratories's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=5183.20/113.45
=45.69

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alkem Laboratories's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, Alkem Laboratories's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=49.76/153.2548*153.2548
=49.760

Current CPI (Dec. 2023) = 153.2548.

Alkem Laboratories Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201203 0.000 76.889 0.000
201303 0.000 85.687 0.000
201403 21.930 91.425 36.761
201412 13.500 96.780 21.378
201503 10.999 97.163 17.349
201506 16.820 99.841 25.819
201509 22.320 101.753 33.617
201512 15.630 102.901 23.278
201603 7.250 102.518 10.838
201606 19.970 105.961 28.883
201609 23.650 105.961 34.206
201612 19.520 105.196 28.438
201703 11.460 105.196 16.696
201706 5.990 107.109 8.571
201709 26.820 109.021 37.702
201712 14.360 109.404 20.116
201803 5.610 109.786 7.831
201806 11.390 111.317 15.681
201809 21.280 115.142 28.324
201812 16.940 115.142 22.547
201903 14.000 118.202 18.152
201906 15.510 120.880 19.664
201909 31.020 123.175 38.595
201912 31.950 126.235 38.789
202003 15.780 124.705 19.393
202006 35.300 127.000 42.597
202009 39.480 130.118 46.500
202012 37.720 130.889 44.165
202103 20.080 131.771 23.354
202106 39.150 134.084 44.747
202109 45.520 135.847 51.353
202112 43.960 138.161 48.763
202203 8.990 138.822 9.925
202206 10.680 142.347 11.498
202209 27.670 144.661 29.314
202212 38.030 145.763 39.985
202303 5.930 146.865 6.188
202306 23.980 150.280 24.455
202309 51.900 151.492 52.504
202312 49.760 153.255 49.760

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Alkem Laboratories  (NSE:ALKEM) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Alkem Laboratories Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Alkem Laboratories's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Alkem Laboratories (NSE:ALKEM) Business Description

Traded in Other Exchanges
Address
Senapati Bapat Marg, Alkem House, Devashish Building, Lower Parel, Mumbai, MH, IND, 400 013
Alkem Laboratories Ltd is an Indian pharmaceutical company engaged in the development, manufacture, and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical ingredients (APIs) and nutraceuticals in acute and chronic therapeutic areas, such as anti-infective, pain and analgesics, vitamins/minerals/nutrients, cardiac and Diabetology, Gynecology, neuro/central nervous system, dermatology, anti-diabetes, anti-osteoporosis, cardiovascular, and muscle relaxants, which are marketed in Indian and International markets. It operates through the pharmaceutical business segment.

Alkem Laboratories (NSE:ALKEM) Headlines

No Headlines